STMN1 and neoplasm: Taking advantage of the previously described in vivo experiments (Fig 2), we analysed tumours from MDAH cells intratumourally injected with stathmin shRNA and verified that stathmin knockdown was associated with a marked downregulation of p53, also when animals were co-treated with CBDCA (Fig 3D).